Skip to main content
. Author manuscript; available in PMC: 2012 Nov 30.
Published in final edited form as: Menopause. 2011 Nov;18(11):1172–1177. doi: 10.1097/gme.0b013e31821b01c7

TABLE 3.

Multivariate analysis for risk of hip fracture and HT use

Risk factors Hazard ratio (95% CI) P
Model 1
 No HT use in the previous yeara 1.55 (1.36–1.77) <0.0001
 Race
  White 1.0
  Black 0.51 (0.38–0.69) <0.0001
  Hispanic 0.74 (0.60–0.91)
  Asian 0.44 (0.31–0.63)
  Unknown 0.30 (0.24–0.37)
  Other 0.51 (0.19–1.37)
 Age (5-y increment) 1.97 (1.89–2.05) <0.0001
Model 2 (adjusted for age and race)
 Total no. of years not on HT after 2002a <0.0001
  0 1.0
  1 1.16 (0.96–1.40)
  2 1.52 (1.26–1.84)
  3 1.64 (1.34–2.00)
  4 1.68 (1.36–2.08)
  ≥5 1.77 (1.44–2.18)

HT, hormone therapy.

a

Variables considered time-dependent in Cox regression model.